Cargando…

Alteration in gut mycobiota of patients with polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is a serious disease characterized by high androgen, insulin resistance (IR), hyperglycemia, and obesity, leading to infertility. The gut mycobiota has been reported to evolve in metabolic diseases including obesity, hyperglycemia, and fatty liver. However, little is...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ke, Geng, Huafeng, Liu, Junbao, Ye, Cong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580825/
https://www.ncbi.nlm.nih.gov/pubmed/37702484
http://dx.doi.org/10.1128/spectrum.02360-23
_version_ 1785122019166126080
author Chen, Ke
Geng, Huafeng
Liu, Junbao
Ye, Cong
author_facet Chen, Ke
Geng, Huafeng
Liu, Junbao
Ye, Cong
author_sort Chen, Ke
collection PubMed
description Polycystic ovary syndrome (PCOS) is a serious disease characterized by high androgen, insulin resistance (IR), hyperglycemia, and obesity, leading to infertility. The gut mycobiota has been reported to evolve in metabolic diseases including obesity, hyperglycemia, and fatty liver. However, little is known about the gut mycobiota and PCOS. In the current study, we recruited 17 PCOS patients and 17 age-matched healthy controls for community structure and functional analysis of the gut mycobiota. The results showed that PCOS patients have reduced diversity and richness of the gut microbiota compared with healthy controls. β-Diversity analysis showed that the community structure of the gut microbiota of patients with PCOS was significantly different from healthy controls. At the phylum level, PCOS patients have reduced Basidiomycota and increased Ascomycota compared with healthy controls. At the family level, the higher relative abundance of Saccharomycetaceae and lower Trichosporonaceae and Ascomycota_unclassified were detected in PCOS patients than in healthy controls. At the genus level, different microbial compositions were also observed between PCOS patients and healthy controls. In addition, PICRUSt2 showed that patients with PCOS have different microbial functions in the gut compared with healthy controls. LEfSe indicated that Saccharomyces and Lentinula were enriched in the fecal samples of PCOS patients, while Aspergillus was depleted compared with healthy controls. Our finding indicates that PCOS patients have different community structures and functions of the gut mycobiota, which provides new insight into PCOS pathogenesis and intervention. IMPORTANCE: It was found that intestinal fungi as well as serum metabolites in PCOS patients were significantly different from those in healthy subjects. However, no studies have been done to show exactly which fungus interacts with which bacteria in humans or which fungus acts alone. As fungal research progresses, it will be possible to fill this gap.
format Online
Article
Text
id pubmed-10580825
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-105808252023-10-18 Alteration in gut mycobiota of patients with polycystic ovary syndrome Chen, Ke Geng, Huafeng Liu, Junbao Ye, Cong Microbiol Spectr Research Article Polycystic ovary syndrome (PCOS) is a serious disease characterized by high androgen, insulin resistance (IR), hyperglycemia, and obesity, leading to infertility. The gut mycobiota has been reported to evolve in metabolic diseases including obesity, hyperglycemia, and fatty liver. However, little is known about the gut mycobiota and PCOS. In the current study, we recruited 17 PCOS patients and 17 age-matched healthy controls for community structure and functional analysis of the gut mycobiota. The results showed that PCOS patients have reduced diversity and richness of the gut microbiota compared with healthy controls. β-Diversity analysis showed that the community structure of the gut microbiota of patients with PCOS was significantly different from healthy controls. At the phylum level, PCOS patients have reduced Basidiomycota and increased Ascomycota compared with healthy controls. At the family level, the higher relative abundance of Saccharomycetaceae and lower Trichosporonaceae and Ascomycota_unclassified were detected in PCOS patients than in healthy controls. At the genus level, different microbial compositions were also observed between PCOS patients and healthy controls. In addition, PICRUSt2 showed that patients with PCOS have different microbial functions in the gut compared with healthy controls. LEfSe indicated that Saccharomyces and Lentinula were enriched in the fecal samples of PCOS patients, while Aspergillus was depleted compared with healthy controls. Our finding indicates that PCOS patients have different community structures and functions of the gut mycobiota, which provides new insight into PCOS pathogenesis and intervention. IMPORTANCE: It was found that intestinal fungi as well as serum metabolites in PCOS patients were significantly different from those in healthy subjects. However, no studies have been done to show exactly which fungus interacts with which bacteria in humans or which fungus acts alone. As fungal research progresses, it will be possible to fill this gap. American Society for Microbiology 2023-09-13 /pmc/articles/PMC10580825/ /pubmed/37702484 http://dx.doi.org/10.1128/spectrum.02360-23 Text en Copyright © 2023 Chen et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Chen, Ke
Geng, Huafeng
Liu, Junbao
Ye, Cong
Alteration in gut mycobiota of patients with polycystic ovary syndrome
title Alteration in gut mycobiota of patients with polycystic ovary syndrome
title_full Alteration in gut mycobiota of patients with polycystic ovary syndrome
title_fullStr Alteration in gut mycobiota of patients with polycystic ovary syndrome
title_full_unstemmed Alteration in gut mycobiota of patients with polycystic ovary syndrome
title_short Alteration in gut mycobiota of patients with polycystic ovary syndrome
title_sort alteration in gut mycobiota of patients with polycystic ovary syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580825/
https://www.ncbi.nlm.nih.gov/pubmed/37702484
http://dx.doi.org/10.1128/spectrum.02360-23
work_keys_str_mv AT chenke alterationingutmycobiotaofpatientswithpolycysticovarysyndrome
AT genghuafeng alterationingutmycobiotaofpatientswithpolycysticovarysyndrome
AT liujunbao alterationingutmycobiotaofpatientswithpolycysticovarysyndrome
AT yecong alterationingutmycobiotaofpatientswithpolycysticovarysyndrome